No increased risk of psoriasis in patients receiving androgen deprivation therapy for prostate cancer: a 17-year population-based study

OBJECTIVE: Androgen deprivation therapy (ADT) use in prostate cancer (PCa) patients has been reported to exacerbate the course of psoriasis. We aimed to assess the impact of ADT on the subsequent risk of psoriasis. METHODS: We utilized data from the National Health Insurance Research Database of Tai...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jui-Ming, Lin, Chien-Yu, Chuang, Heng-Chang, Hsu, Ren-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168069/
https://www.ncbi.nlm.nih.gov/pubmed/30319264
http://dx.doi.org/10.2147/TCRM.S175244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168069/
https://www.ncbi.nlm.nih.gov/pubmed/30319264
http://dx.doi.org/10.2147/TCRM.S175244

Ejemplares similares